Ardena’s New State-of-the-Art Nanomedicine Facility Secures Full GMP Approval for Manufacturing
November 19, 2024 05:27 ET
|
Ardena Holding NV.
Ardena’s Oss facility secures GMP approval for nanomedicine manufacturing, enhancing capabilities in innovative drug development.
Ardena Expands Bioanalytical Services in Europe
October 29, 2024 07:24 ET
|
Ardena Holding NV.
Ardena expands bioanalytical services in the Netherlands with a new lab in Oss and enhanced capabilities in Assen to meet rising client demand.
Ardena, 미국 내 입지 확대 목표로 Catalent의 첨단 의약품 제조 시설 인수 계약 체결
October 16, 2024 05:24 ET
|
Ardena Holding NV.
벨기에 겐트, Oct. 16, 2024 (GLOBE NEWSWIRE) -- 유럽의 벨기에, 스페인, 네덜란드, 스웨덴에 GMP 시설을 보유한 전문 의약품 위탁 개발 및 생산업체(CDMO) Ardena가 미국 뉴저지주 서머셋 (Somerset)에 위치한 Catalent의 첨단 시설을 인수하는 내용의 최종 계약을 체결했다고 이번 주에 발표했다. 이번 인수를...
Ardena erweitert US-Präsenz und unterzeichnet Vereinbarung zur Akquisition einer hochmodernen Herstellungsanlage für Arzneimittel von Catalent
October 15, 2024 14:44 ET
|
Ardena Holding NV.
GENT, Belgien, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Ardena, ein auf Auftragsentwicklung und -herstellung spezialisiertes, Pharmaunternehmen (Contract Development and Manufacturing Organisation, CDMO)...
Ardena Signs Agreement to Expand US Footprint with the Acquisition of Advanced Drug Product Manufacturing Facility from Catalent
October 14, 2024 06:00 ET
|
Ardena Holding NV.
Ardena acquires Catalent's Somerset, NJ facility, expanding its US presence and boosting advanced oral drug product manufacturing capabilities.
Ardena élargit sa présence aux États-Unis avec l’acquisition d’une unité de production pharmaceutique du réseau Catalent
October 14, 2024 06:00 ET
|
Ardena Holding NV.
Gand, Belgique, 14 oct. 2024 (GLOBE NEWSWIRE) -- Ardena, un sous-traitant pharmaceutique (ou CDMO pour Contract Development and Manufacturing Organisation) spécialisé dans le développement de...